Aditxt Inc (ADTX) Gross Profit Margin starting from the first quarter 2026 to first quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Aditxt Inc   (NASDAQ: ADTX)


Aditxt Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADTX Gross Profit Margin (Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2 		(Mar 31 2025)
Q1
Y / Y Revenue Change 1120 %
Seq. Revenue Change 2340 %
Revenue In Millions $0.01
Gross Profit Margin 23.77 %
Gross Profit Margin Total Ranking # 1949
Gross Profit In Millions $0.00
Y / Y Gross Profit Change 866.67 %
Seq. Gross Profit Change -


Commenting First Quarter 2026 Gross Profit Margin
Aditxt Inc achieved Gross Profit of $0 millions compare to Gross Loss of $0.00 millions recorded in the previous quarter. Revenue increased by 2340 % Company accomplished above average Gross Profit Margin with 23.77 %.


Observing first quarter 2026 results within Major Pharmaceutical Preparations industry 128 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1949, from total ranking in the previous quarter at 3331.
Learn about Gross Margin
ADTX's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 129
Healthcare Sector # 355
Overall # 1927

Gross Profit Margin Statistics
High Average Low
47.75 % 21.13 % 8.31 %
(Jun 30 2024)   (Dec 31 2022)


ADTX Gross Income Trends • More of ADTX's Profitabilty Ratios • ADTX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ADTX's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ADTX's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ADTX's Competitors
Gross Profit Margin Profit Margin for Aditxt Inc 's Suppliers
Gross Profit Margin Profit Margin for ADTX's Customers

You may also want to know
ADTX's Annual Growth Rates ADTX's Profitability Ratios ADTX's Asset Turnover Ratio ADTX's Dividend Growth
ADTX's Roe ADTX's Valuation Ratios ADTX's Financial Strength Ratios ADTX's Gross Profit Growth
ADTX's Roa ADTX's Inventory Turnover Ratio ADTX's Growth Rates ADTX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Zomedica Corp   64.64 %$ 5.484  Millions$ 8.484  Millions
Eton Pharmaceuticals Inc   62.08 %$ 14.735  Millions$ 23.735  Millions
Harrow Inc   61.40 %$ 27.045  Millions$ 44.045  Millions
Fortress Biotech Inc   61.23 %$ 9.820  Millions$ 16.038  Millions
Journey Medical Corp  61.04 %$ 9.743  Millions$ 15.961  Millions
Ani Pharmaceuticals Inc  60.59 %$ 143.880  Millions$ 237.462  Millions
International Stem Cell Corporation  58.79 %$ 1.361  Millions$ 2.315  Millions
Elanco Animal Health Incorporated  57.26 %$ 785.000  Millions$ 1,371.000  Millions
Abbott Laboratories  56.20 %$ 6,274.000  Millions$ 11,164.000  Millions
Vireo Growth Inc.  55.84 %$ 59.300  Millions$ 106.200  Millions
Polomar Health Services, Inc.  54.75 %$ 0.551  Millions$ 1.006  Millions
Evofem Biosciences Inc   54.39 %$ 0.489  Millions$ 0.899  Millions
Emergent Biosolutions Inc   53.88 %$ 84.100  Millions$ 156.100  Millions
Organon and Co   53.63 %$ 783.000  Millions$ 1,460.000  Millions
Siga Technologies Inc  52.89 %$ 3.302  Millions$ 6.243  Millions
Dr Reddy s Laboratories Limited  52.77 %$ 1,889.000  Millions$ 3,580.000  Millions
Reshape Lifesciences Inc  52.69 %$ 0.017  Millions$ 0.032  Millions
Prestige Consumer Healthcare Inc   51.82 %$ 146.299  Millions$ 282.299  Millions
Maravai Lifesciences Holdings Inc   51.29 %$ 33.701  Millions$ 65.701  Millions
Elite Pharmaceuticals Inc   50.98 %$ 20.772  Millions$ 40.748  Millions
Schrodinger Inc   50.43 %$ 29.547  Millions$ 58.587  Millions
Teva Pharmaceutical Industries Limited  49.51 %$ 1,972.000  Millions$ 3,983.000  Millions
Cv Sciences Inc   48.89 %$ 1.562  Millions$ 3.195  Millions
60 Degrees Pharmaceuticals Inc   47.12 %$ 0.076  Millions$ 0.162  Millions
Cryoport inc   45.85 %$ 21.913  Millions$ 47.798  Millions
Amneal Pharmaceuticals Inc   44.33 %$ 320.113  Millions$ 722.113  Millions
Amphastar Pharmaceuticals Inc   41.08 %$ 70.322  Millions$ 171.171  Millions
Nrx Pharmaceuticals Inc   40.92 %$ 0.437  Millions$ 1.068  Millions
Keenova Therapeutics Plc  39.91 %$ 186.600  Millions$ 467.600  Millions
Amarin Corp Plcuk  39.37 %$ 17.769  Millions$ 45.132  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.